Business Context and Reporting Period
This Form 8-K Current Report is filed by Doximity, Inc. for the reporting period of June 10, 2025. The filing addresses a change in executive leadership and related compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Executive Departure: Dr. Nathan Gross is stepping down as Chief Strategy Officer, effective June 16, 2025.
- Role Transition: Dr. Gross will transition to an external advisor role under an Independent Contractor Agreement dated June 13, 2025.
- Compensation Adjustment: Dr. Gross will receive no cash compensation for advisory services. However, existing restricted stock unit and option awards will continue to vest through September 2025 per original terms.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors beyond the standard disclosure regarding the transition of a senior officer. The company notes that the summary of the Advisor Agreement is subject to the complete text of the agreement, which will be filed as an exhibit to the Form 10-Q for the quarter ending June 30, 2025.
Investor Verification Checklist
- Verify the full terms of the Independent Contractor Agreement (Advisor Agreement) when filed as an exhibit to the Q2 2025 Form 10-Q.
- Confirm the vesting schedule details for Dr. Gross's equity awards through September 2025.
- Review the blog post referenced in Item 7.01 (Exhibit 99.1) for additional context on the strategic rationale for the transition.